Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000090

CEO & President gave up 6,554 shares (to pay taxes)

  • CEO & President acquired 16,326 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kewalramani Reshma · CEO & President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-17 Grant or award : show line 1 in the form +16,326 149,813 D
2026-02-17 Shares withheld for taxes : show line 2 in the form −6,554 $483.75 $3,170,498 143,259 D
Loading xslF345X05/wk-form4_1771535794.xml…